Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;37(1):45-51.
doi: 10.1007/s12288-020-01316-6. Epub 2020 Jul 9.

Clinical and Laboratory Profiles of 17 Cases of Chronic Granulomatous Disease in North India

Affiliations

Clinical and Laboratory Profiles of 17 Cases of Chronic Granulomatous Disease in North India

Sabina Langer et al. Indian J Hematol Blood Transfus. 2021 Jan.

Abstract

A primary immune deficiency disorder is often suspected in children with recurrent deep seated and fungal infections and those admitted to pediatric intensive care units. Chronic granulomatous disease (CGD) is inherited disorder leading to infections caused due to defective superoxide production. Cases referred for testing for a primary immunodeficiency disorder were tested for Dihydrorhodamine 123 (DHR) assay by flow cytometry and nitroblue tetrazolium dye (NBT) slide test. The unstimulated and stimulated samples were tested for oxidative burst activity which gives bright fluorescence due to formation of Rhodamine 123 on flow cytometry and blue formazan pigment in NBT slide test. The test results were reported in real time. From a total of 330 patients screened for chronic granulomatous disease using DHR and NBT slide test, 17 patients (5.1%) were found to have CGD. These included 12 boys and 5 girls. They presented with deep seated infections, recurrent and multiple abscess, recurrent pneumonia and granulomatous lymphadenitis. The causative organisms were Mycobacteriae, Staphylococcus, Burkholderia cepacia, Pseudomonas, Aspergillus and Cytomegalovirus. In 6 out of 17 positive cases family studies were carried out. On follow up five children succumbed to disease, two patients underwent allogeneic bone marrow transplant, the chimerism status was demonstrated by repeat DHR assay at day 50 post-transplant. Rest are in follow up under prophylactic antibiotics and supportive care. As facilities for molecular testing are not easily available for primary immuno deficiency disorders, flow cytometry based clinical laboratories can help to screen for some of the frequently suspected disorders like chronic granulomatous disease. This has aided in paediatric care in our centre.

Keywords: Chronic granulomatous disease; DHR assay; Primary immunodeficiency diseases.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow cytometric DHR assay: There is no log shift seen in the histogram of the  stim tube compared to non stim tube after stimulation with PMA. This suggests lack of NADPH oxidase activity in granulocytes suggestive of Chronic Granulomatous disease
Fig. 2
Fig. 2
Flow cytometric DHR assay: There is as significant log shift seen in the histogram of the stim tube compared to non stim tube after stimulation with PMA. This suggests intact NADPH oxidase activity in granulocytes as seen in a Normal control
Fig. 3
Fig. 3
Flow cytometric DHR assay: There were 2 peaks seen after stimulation with PMA in the histogram of the stimulated tube; one corresponding to normal activity in a population of granulocytes and second lagging behind due to absent or reduce activity of enzyme NADPH oxidase. Log shift seen in the stim tube compared to non stim tube. This suggests heterozygous carrier state which was seen in the mother

Similar articles

Cited by

References

    1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Med (Baltimore) 2000;79:170–200. doi: 10.1097/00005792-200005000-00004. - DOI - PubMed
    1. Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood. 2009;114:2619–2622. doi: 10.1182/blood-2009-05-221606. - DOI - PMC - PubMed
    1. Arnold DE, Heimall JR. A review of chronic granulomatous disease. Adv Therapy. 2017;34:2543–2557. doi: 10.1007/s12325-017-0636-2. - DOI - PMC - PubMed
    1. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy. 2011;9:10. doi: 10.1186/1476-7961-9-10. - DOI - PMC - PubMed
    1. Verma S, Sharma PK, Sivanandan S, Rana N, Saini S, Lodha R, et al. Spectrum of primary immune deficiency at a tertiary care hospital. Indian J Pediatr. 2008;75:143–148. doi: 10.1007/s12098-008-0022-9. - DOI - PubMed

LinkOut - more resources